Factors Influencing the Selection of Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Non-Valvular Atrial Fibrillation
S Park, NK Je - Journal of Cardiovascular Pharmacology …, 2021 - journals.sagepub.com
Background: Major atrial fibrillation (AF) guidelines recommend non-vitamin K antagonist
oral anticoagulants (NOACs) over warfarin, except in rare clinical circumstances based on 4 …
oral anticoagulants (NOACs) over warfarin, except in rare clinical circumstances based on 4 …
Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic …
The non-vitamin K antagonist oral anticoagulants (NOACs) have been increasingly
prescribed in clinical practice for stroke prevention in patients with nonvalvular atrial …
prescribed in clinical practice for stroke prevention in patients with nonvalvular atrial …
Use of non‐vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic
Background Non‐vitamin K antagonist oral anticoagulants (NOAC s) are broadly preferable
to vitamin K antagonists (VKA s) for stroke prevention in non‐valvular atrial fibrillation (AF) …
to vitamin K antagonists (VKA s) for stroke prevention in non‐valvular atrial fibrillation (AF) …
[HTML][HTML] Effectiveness and safety of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation patients: Results of A real-world study in a metropolitan area of …
E Crocetti, S Cattaneo, W Bergamaschi… - Journal of Clinical …, 2021 - mdpi.com
Background: New oral anticoagulant agents (NOACs) are valid alternatives for vitamin K
antagonists (VKA) in patients with non-valvular atrial fibrillation (NVAF) for stroke prevention …
antagonists (VKA) in patients with non-valvular atrial fibrillation (NVAF) for stroke prevention …
[HTML][HTML] Rationale and design of a prospective, multicenter, cross-sectional study of appropriateness evaluation of the prescription of non-vitamin K antagonist oral …
Z Ding, C Zhang, YY Qian, N Wang, ZC Gu… - Annals of …, 2021 - ncbi.nlm.nih.gov
Background Non-vitamin K antagonist oral anticoagulants (NOACs) are alternative to
vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation (AF) …
vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation (AF) …
Comparative effectiveness and safety of non–vitamin K antagonist oral anticoagulants in atrial fibrillation patients
Background and Purpose: Several observational studies have compared the effect of the
non–vitamin K antagonist oral anticoagulants to each other in patients with atrial fibrillation …
non–vitamin K antagonist oral anticoagulants to each other in patients with atrial fibrillation …
[HTML][HTML] Shifting from vitamin K antagonists to non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: predictors, patterns and temporal trends
Abstract Background Non-Vitamin K antagonist oral anticoagulants (NOACs) emerged as an
alternative with comparable or superior efficacy and safety to vitamin K antagonists (VKAs) …
alternative with comparable or superior efficacy and safety to vitamin K antagonists (VKAs) …
[HTML][HTML] Reappraisal of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: a systematic review and meta-analysis
Background: Recent observational studies have compared effectiveness and safety profiles
between non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in patients with …
between non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in patients with …
Practical considerations for the nonvitamin K antagonist oral anticoagulants
R Trikha, PR Kowey - Cardiology, 2017 - karger.com
Abstract Objectives: Dabigatran, rivaroxaban, apixaban, and edoxaban are nonvitamin K
antagonist oral anticoagulants (NOACs) approved for stroke prevention in patients with …
antagonist oral anticoagulants (NOACs) approved for stroke prevention in patients with …
Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysis
M Grymonprez, C Simoens, S Steurbaut… - EP …, 2022 - academic.oup.com
Aims Non-vitamin K antagonist oral anticoagulants (NOACs) are effective and safe
alternatives compared with vitamin K antagonists (VKAs) for thromboembolic prevention in …
alternatives compared with vitamin K antagonists (VKAs) for thromboembolic prevention in …